Literature DB >> 7991252

Hemostatic assessment of patients before tonsillectomy: a prospective study.

H L Close1, T C Kryzer, J H Nowlin, B M Alving.   

Abstract

The purpose of this prospective study in patients undergoing tonsillectomy was to determine whether perioperative bleeding could be predicted by use of a standardized questionnaire concerning bleeding risk combined with measurement of the activated partial thromboplastin time and prothrombin time. Of the 96 patients enrolled in the study, none had a history of a severe bleeding disorder, but 6 (6%) had histories suggestive of a mild bleeding disorder. Further evaluation showed possible von Willebrand's disease in one of these patients. Of the 90 patients with negative questionnaires, 16% had prolongation of the activated partial thromboplastin time. One of these patients had possible von Willebrand's disease. However, none of the patients with positive questionnaires or a prolonged activated partial thromboplastin time bled after surgery. Bleeding that resulted in additional hospital use occurred in 2% of patients, and blood-tinged sputum was described by 4% after discharge; all of these patients had negative questionnaires and normal screening studies. The data provide further evidence that routine measurement of the activated partial thromboplastin time and prothrombin time in asymptomatic patients is not useful for predicting postoperative bleeding. In addition, histories suggestive of a mild bleeding disorder are also not accurate predictors of postoperative bleeding. Excessive bleeding associated with tonsillectomy is usually not a result of an identifiable coagulation disorder.

Entities:  

Mesh:

Year:  1994        PMID: 7991252     DOI: 10.1177/019459989411100606

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  12 in total

1.  Tonsillectomy in children.

Authors:  Boris A Stuck; Karl Götte; Jochen P Windfuhr; Harald Genzwürker; Horst Schroten; Tobias Tenenbaum
Journal:  Dtsch Arztebl Int       Date:  2008-12-05       Impact factor: 5.594

Review 2.  Etiology and management of coagulation abnormalities in the pain management patient.

Authors:  E Cobos; J C Cruz; M Day
Journal:  Curr Rev Pain       Date:  2000

3.  Occurrence of coagulation factor deficiency in post-tonsillectomy hemorrhage.

Authors:  Michaela Zumtobel; Klemens Frei
Journal:  Wien Klin Wochenschr       Date:  2011-04-11       Impact factor: 1.704

Review 4.  [Perioperative coagulation diagnostics].

Authors:  C-E Dempfle
Journal:  Anaesthesist       Date:  2005-02       Impact factor: 1.041

5.  [Risk of hemorrhage after adenoidectomy and tonsillectomy. Value of the preoperative determination of partial thromboplastin time, prothrombin time and platelet count].

Authors:  K Scheckenbach; H Bier; T K Hoffmann; J P Windfuhr; M Bas; H-J Laws; C Plettenberg; M Wagenmann
Journal:  HNO       Date:  2008-03       Impact factor: 1.284

Review 6.  [Tonsillectomy in children: preoperative evaluation of risk factors].

Authors:  B A Stuck; H V Genzwürker
Journal:  Anaesthesist       Date:  2008-05       Impact factor: 1.041

7.  The value of routine preoperative testing in the prediction of operative hemorrhage in adenotonsillectomy.

Authors:  Galila Zaher; Khaled Al-Noury
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2011-08-27

8.  Preoperative coagulation screening prior to tonsillectomy in adults: current practice and recommendations.

Authors:  Stephanie Sarny; Guenther Ossimitz; Walter Habermann; Heinz Stammberger
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-07-12       Impact factor: 2.503

Review 9.  Malpractice claims and unintentional outcome of tonsil surgery and other standard procedures in otorhinolaryngology.

Authors:  Jochen P Windfuhr
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2013-12-13

10.  The Role of Bleeding History and Clinical Markers for the Correct Diagnosis of VWD.

Authors:  Alberto Tosetto
Journal:  Mediterr J Hematol Infect Dis       Date:  2013-07-12       Impact factor: 2.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.